Increased incidence of fungemia caused by Candida krusei

W. G. Merz, Judith Karp, D. Schron, R. Saral

Research output: Contribution to journalArticle

Abstract

Candida krusei colonized 12.4% of 868 patients undergoing episodes of therapy-induced granulocytopenia over a 9-year period. The gastrointestinal tract was most frequently colonized, followed by the respiratory tract and urinary tract. Ten patients developed systemic infections with Candida krusei; all 10 had two or more positive blood cultures. Nine of the 10 patients were colonized with Candida krusei, and 6 were receiving systemic antifungal agents at the time of development of the infection. Seven patients died within 1 month of Candida krusei sepsis; systemic candidiasis was seen in the autopsies of the four patients on whom autopsies were performed. Therefore, Candida krusei should be recognized as an emerging pathogen in select patient populations.

Original languageEnglish (US)
Pages (from-to)581-584
Number of pages4
JournalJournal of Clinical Microbiology
Volume24
Issue number4
StatePublished - 1986

Fingerprint

Fungemia
Candida
Incidence
Autopsy
Agranulocytosis
Antifungal Agents
Urinary Tract
Respiratory System
Gastrointestinal Tract
Sepsis
Infection
Population

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Increased incidence of fungemia caused by Candida krusei. / Merz, W. G.; Karp, Judith; Schron, D.; Saral, R.

In: Journal of Clinical Microbiology, Vol. 24, No. 4, 1986, p. 581-584.

Research output: Contribution to journalArticle

Merz, WG, Karp, J, Schron, D & Saral, R 1986, 'Increased incidence of fungemia caused by Candida krusei', Journal of Clinical Microbiology, vol. 24, no. 4, pp. 581-584.
Merz, W. G. ; Karp, Judith ; Schron, D. ; Saral, R. / Increased incidence of fungemia caused by Candida krusei. In: Journal of Clinical Microbiology. 1986 ; Vol. 24, No. 4. pp. 581-584.
@article{14f1acc667b249de8930423b836b94bf,
title = "Increased incidence of fungemia caused by Candida krusei",
abstract = "Candida krusei colonized 12.4{\%} of 868 patients undergoing episodes of therapy-induced granulocytopenia over a 9-year period. The gastrointestinal tract was most frequently colonized, followed by the respiratory tract and urinary tract. Ten patients developed systemic infections with Candida krusei; all 10 had two or more positive blood cultures. Nine of the 10 patients were colonized with Candida krusei, and 6 were receiving systemic antifungal agents at the time of development of the infection. Seven patients died within 1 month of Candida krusei sepsis; systemic candidiasis was seen in the autopsies of the four patients on whom autopsies were performed. Therefore, Candida krusei should be recognized as an emerging pathogen in select patient populations.",
author = "Merz, {W. G.} and Judith Karp and D. Schron and R. Saral",
year = "1986",
language = "English (US)",
volume = "24",
pages = "581--584",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Increased incidence of fungemia caused by Candida krusei

AU - Merz, W. G.

AU - Karp, Judith

AU - Schron, D.

AU - Saral, R.

PY - 1986

Y1 - 1986

N2 - Candida krusei colonized 12.4% of 868 patients undergoing episodes of therapy-induced granulocytopenia over a 9-year period. The gastrointestinal tract was most frequently colonized, followed by the respiratory tract and urinary tract. Ten patients developed systemic infections with Candida krusei; all 10 had two or more positive blood cultures. Nine of the 10 patients were colonized with Candida krusei, and 6 were receiving systemic antifungal agents at the time of development of the infection. Seven patients died within 1 month of Candida krusei sepsis; systemic candidiasis was seen in the autopsies of the four patients on whom autopsies were performed. Therefore, Candida krusei should be recognized as an emerging pathogen in select patient populations.

AB - Candida krusei colonized 12.4% of 868 patients undergoing episodes of therapy-induced granulocytopenia over a 9-year period. The gastrointestinal tract was most frequently colonized, followed by the respiratory tract and urinary tract. Ten patients developed systemic infections with Candida krusei; all 10 had two or more positive blood cultures. Nine of the 10 patients were colonized with Candida krusei, and 6 were receiving systemic antifungal agents at the time of development of the infection. Seven patients died within 1 month of Candida krusei sepsis; systemic candidiasis was seen in the autopsies of the four patients on whom autopsies were performed. Therefore, Candida krusei should be recognized as an emerging pathogen in select patient populations.

UR - http://www.scopus.com/inward/record.url?scp=0022538862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022538862&partnerID=8YFLogxK

M3 - Article

C2 - 3771746

AN - SCOPUS:0022538862

VL - 24

SP - 581

EP - 584

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 4

ER -